Almazov National Medical Research Centre   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Moscow Russian Federation (1980)

Organization Overview

First Clinical Trial
2018
NCT04377399
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Almazov National Medical Research Centre

Active Ingredients

Drugs in Phase 4 Trials (1)

vitamin d3 (1 trial)

Drugs in Phase 3 Trials (1)

insulin human (humulin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 1 (Phase 3)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Neuropathies (Phase 4)

Peripheral Nervous System Diseases (Phase 4)

Vitamin D Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2